Including information about co-morbidity in estimates of disease burden: results from the World Health Organization World Mental Health Surveys
- PMID: 20553636
- PMCID: PMC3045479
- DOI: 10.1017/S0033291710001212
Including information about co-morbidity in estimates of disease burden: results from the World Health Organization World Mental Health Surveys
Abstract
Background: The methodology commonly used to estimate disease burden, featuring ratings of severity of individual conditions, has been criticized for ignoring co-morbidity. A methodology that addresses this problem is proposed and illustrated here with data from the World Health Organization World Mental Health Surveys. Although the analysis is based on self-reports about one's own conditions in a community survey, the logic applies equally well to analysis of hypothetical vignettes describing co-morbid condition profiles.
Method: Face-to-face interviews in 13 countries (six developing, nine developed; n=31 067; response rate=69.6%) assessed 10 classes of chronic physical and nine of mental conditions. A visual analog scale (VAS) was used to assess overall perceived health. Multiple regression analysis with interactions for co-morbidity was used to estimate associations of conditions with VAS. Simulation was used to estimate condition-specific effects.
Results: The best-fitting model included condition main effects and interactions of types by numbers of conditions. Neurological conditions, insomnia and major depression were rated most severe. Adjustment for co-morbidity reduced condition-specific estimates with substantial between-condition variation (0.24-0.70 ratios of condition-specific estimates with and without adjustment for co-morbidity). The societal-level burden rankings were quite different from the individual-level rankings, with the highest societal-level rankings associated with conditions having high prevalence rather than high individual-level severity.
Conclusions: Plausible estimates of disorder-specific effects on VAS can be obtained using methods that adjust for co-morbidity. These adjustments substantially influence condition-specific ratings.
Conflict of interest statement
References
-
- Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. European Journal of Neurology. 2005;12(Suppl 1):1–27. - PubMed
-
- Baker M, Stabile M, Deri C. What do Self-Reported, Objective, Measures of Health Measure? Journal of Human Resources. 2001;39:1067–1093.
-
- Breiman L. Random forests. Machine Learning. 2001;45:32.
-
- Breiman L. Statistical modeling: the two cultures. Statistical Science. 2009;16:199–215.
-
- Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. Chapman & Hall; New York, NY: 1984.
Publication types
MeSH terms
Grants and funding
- R01 DA016558/DA/NIDA NIH HHS/United States
- U01-MH60220/MH/NIMH NIH HHS/United States
- R03 TW006481/TW/FIC NIH HHS/United States
- U01 MH060220/MH/NIMH NIH HHS/United States
- R13-MH066849/MH/NIMH NIH HHS/United States
- HHSN271200700030C/MH/NIMH NIH HHS/United States
- R01 MH070884/MH/NIMH NIH HHS/United States
- R13 MH066849/MH/NIMH NIH HHS/United States
- R01 MH069864/MH/NIMH NIH HHS/United States
- R01-MH61905/MH/NIMH NIH HHS/United States
- R01MH070884/MH/NIMH NIH HHS/United States
- R01 MH061905/MH/NIMH NIH HHS/United States
- R01-MH069864/MH/NIMH NIH HHS/United States
- K05 DA015799/DA/NIDA NIH HHS/United States
- R03-TW006481/TW/FIC NIH HHS/United States
- R01 MH059575/MH/NIMH NIH HHS/United States
- U13 MH066849/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
